Matt Hewitt's Stock Ratings

Craig-Hallum Analyst

Matt Hewitt is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

7.76%

Smart Score

58.9%

Overall Average Return Percentile

57th

Number of Ratings

56
Buy NowGet Alert
03/12/2025CSBRBuy Now
Champions Oncology
$10.1518.23%
Matt Hewitt58%
$8 → $12MaintainsBuyGet Alert
12/12/2024CSBRBuy Now
Champions Oncology
$10.15-21.18%
Matt Hewitt58%
$6 → $8MaintainsBuyGet Alert
11/13/2024BLFSBuy Now
BioLife Solns
$25.3326.33%
Matt Hewitt58%
$30 → $32MaintainsBuyGet Alert
10/31/2024OMCLBuy Now
Omnicell
$33.3591.9%
Matt Hewitt58%
$45 → $64MaintainsBuyGet Alert
09/12/2024CSBRBuy Now
Champions Oncology
$10.15-40.89%
Matt Hewitt58%
$6 → $6UpgradeHold → BuyGet Alert
08/12/2024BLFSBuy Now
BioLife Solns
$25.3318.44%
Matt Hewitt58%
$23 → $30MaintainsBuyGet Alert
07/09/2024LGNDBuy Now
Ligand Pharmaceuticals
$106.2231.8%
Matt Hewitt58%
$135 → $140MaintainsBuyGet Alert
07/03/2024SLPBuy Now
Simulations Plus
$25.36120.82%
Matt Hewitt58%
$56 → $56ReiteratesBuy → BuyGet Alert
06/13/2024SLPBuy Now
Simulations Plus
$25.36120.82%
Matt Hewitt58%
$51 → $56MaintainsBuyGet Alert
05/16/2024NOTVBuy Now
Inotiv
$3.07225.73%
Matt Hewitt58%
$25 → $10MaintainsBuyGet Alert
05/02/2024SDGRBuy Now
Schrodinger
$22.9530.72%
Matt Hewitt58%
$35 → $30MaintainsBuyGet Alert
03/13/2024CSBRBuy Now
Champions Oncology
$10.15—
Matt Hewitt58%
—DowngradeBuy → HoldGet Alert
01/29/2024SNCEBuy Now
Science 37 Hldgs
——
Matt Hewitt58%
—DowngradeBuy → HoldGet Alert
01/19/2024SDGRBuy Now
Schrodinger
$22.9552.51%
Matt Hewitt58%
$40 → $35MaintainsBuyGet Alert
01/04/2024SLPBuy Now
Simulations Plus
$25.36101.1%
Matt Hewitt58%
$50 → $51MaintainsBuyGet Alert
01/04/2024AGTIBuy Now
Agiliti
——
Matt Hewitt58%
→ $23Initiates → BuyGet Alert
12/12/2023NOTVBuy Now
Inotiv
$3.07714.33%
Matt Hewitt58%
$34 → $25MaintainsBuyGet Alert
12/08/2023CDMOBuy Now
Avid Bioservices
——
Matt Hewitt58%
$22 → $16MaintainsBuyGet Alert
11/29/2023MXCTBuy Now
MaxCyte
$3.19119.44%
Matt Hewitt58%
→ $7Initiates → BuyGet Alert
08/10/2023BLFSBuy Now
BioLife Solns
$25.33-9.2%
Matt Hewitt58%
$29 → $23MaintainsBuyGet Alert
08/03/2023RGENBuy Now
Repligen
$143.8039.08%
Matt Hewitt58%
$207 → $200MaintainsBuyGet Alert
07/11/2023BLFSBuy Now
BioLife Solns
$25.3314.49%
Matt Hewitt58%
→ $29Initiates → BuyGet Alert
04/13/2023OABIBuy Now
OmniAb
$3.14218.47%
Matt Hewitt58%
→ $10Initiates → BuyGet Alert
03/31/2023SRGABuy Now
Surgalign Holdings
——
Matt Hewitt58%
$5 → $2MaintainsHoldGet Alert
07/07/2022SLPBuy Now
Simulations Plus
$25.36136.59%
Matt Hewitt58%
$55 → $60MaintainsBuyGet Alert
06/07/2022SNCEBuy Now
Science 37 Hldgs
——
Matt Hewitt58%
→ $200Initiates → BuyGet Alert
05/24/2022CTEKBuy Now
CynergisTek
——
Matt Hewitt58%
$3 → $1.25DowngradeBuy → HoldGet Alert
04/28/2022TDOCBuy Now
Teladoc Health
$8.38258%
Matt Hewitt58%
$67 → $30MaintainsHoldGet Alert
02/23/2022TDOCBuy Now
Teladoc Health
$8.38699.52%
Matt Hewitt58%
$82 → $67MaintainsHoldGet Alert
01/04/2022ISPCBuy Now
iSpecimen
$1.341392.54%
Matt Hewitt58%
→ $400Initiates → BuyGet Alert
12/08/2021CDMOBuy Now
Avid Bioservices
——
Matt Hewitt58%
$29 → $35MaintainsBuyGet Alert
11/03/2021OMCLBuy Now
Omnicell
$33.35514.69%
Matt Hewitt58%
$170 → $205MaintainsBuyGet Alert
10/26/2021SLPBuy Now
Simulations Plus
$25.36108.99%
Matt Hewitt58%
$65 → $53UpgradeHold → BuyGet Alert
09/28/2021SRGABuy Now
Surgalign Holdings
——
Matt Hewitt58%
→ $45DowngradeBuy → HoldGet Alert
09/27/2021RGENBuy Now
Repligen
$143.80155.91%
Matt Hewitt58%
$258 → $368MaintainsBuyGet Alert
09/20/2021NOTVBuy Now
Inotiv
$3.071365.8%
Matt Hewitt58%
→ $45Initiates → BuyGet Alert
06/30/2021CDMOBuy Now
Avid Bioservices
——
Matt Hewitt58%
$21 → $29MaintainsBuyGet Alert
05/25/2021SDGRBuy Now
Schrodinger
$22.95270.37%
Matt Hewitt58%
→ $85Initiates → BuyGet Alert
01/12/2021SLPBuy Now
Simulations Plus
$25.36—
Matt Hewitt58%
—DowngradeBuy → HoldGet Alert
10/21/2020LGNDBuy Now
Ligand Pharmaceuticals
$106.2283.58%
Matt Hewitt58%
$215 → $195MaintainsBuyGet Alert
07/28/2020VCRABuy Now
Vocera Communications
——
Matt Hewitt58%
$21 → $30UpgradeHold → BuyGet Alert
01/06/2020SLPBuy Now
Simulations Plus
$25.3657.73%
Matt Hewitt58%
→ $40Initiates → BuyGet Alert
10/25/2019VCRABuy Now
Vocera Communications
——
Matt Hewitt58%
→ $21DowngradeBuy → HoldGet Alert
10/16/2019CDMOBuy Now
Avid Bioservices
——
Matt Hewitt58%
→ $11Initiates → BuyGet Alert
07/26/2019OMCLBuy Now
Omnicell
$33.35154.87%
Matt Hewitt58%
→ $85UpgradeHold → BuyGet Alert
04/26/2019OMCLBuy Now
Omnicell
$33.35—
Matt Hewitt58%
—DowngradeBuy → HoldGet Alert
07/27/2018OMCLBuy Now
Omnicell
$33.35—
Matt Hewitt58%
—UpgradeHold → BuyGet Alert
06/05/2018TDOCBuy Now
Teladoc Health
$8.38—
Matt Hewitt58%
—UpgradeHold → BuyGet Alert
07/24/2017APENBuy Now
Apollo Endosurgery
——
Matt Hewitt58%
→ $11Initiates → BuyGet Alert
05/12/2017TDOCBuy Now
Teladoc Health
$8.38—
Matt Hewitt58%
—DowngradeBuy → HoldGet Alert
11/28/2016TDOCBuy Now
Teladoc Health
$8.38—
Matt Hewitt58%
—Initiates → BuyGet Alert
02/22/2016RGENBuy Now
Repligen
$143.80—
Matt Hewitt58%
—Initiates → BuyGet Alert
05/12/2015LGNDBuy Now
Ligand Pharmaceuticals
$106.22-1.15%
Matt Hewitt58%
$90 → $105MaintainsBuyGet Alert
04/24/2015VCRABuy Now
Vocera Communications
——
Matt Hewitt58%
—UpgradeHold → BuyGet Alert
08/01/2014VCRABuy Now
Vocera Communications
——
Matt Hewitt58%
$23 → $10DowngradeBuy → HoldGet Alert
04/09/2014OMCLBuy Now
Omnicell
$33.35-1.05%
Matt Hewitt58%
$28 → $33UpgradeHold → BuyGet Alert